Deciphera stock surges on gastrointestinal cancer drug success

Allison DeAngelis
Deciphera stock surges on gastrointestinal cancer drug success

After sixteen years of work, Waltham drugmaker Deciphera Pharmaceuticals Inc. is set to ask the FDA for permission to bring its first product to market next year.